BenQ BM Holding Cayman (HKSE:02581) Research & Development: HK$0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02581 BenQ BM Holding Cayman Corp HKSE:02581
16 GF Score
Price HK$2.58
! 3 Warning Signs
View Full Analysis

What is BenQ BM Holding Cayman Research & Development?

BenQ BM Holding Cayman HKSE:02581 -1.71% 16 Research & Development is HK$0 Mil as of Dec. 2025. GuruFocus rates HKSE:02581 with a GF Score™ of 16/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. BenQ BM Holding Cayman's Research & Development for the six months ended in Dec. 2025 was HK$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0 Mil.

BenQ BM Holding Cayman  (HKSE:02581) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BenQ BM Holding Cayman Research & Development Related Terms

BenQ BM Holding Cayman Research & Development Historical Data

* Premium members only.

The historical data trend for BenQ BM Holding Cayman's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BenQ BM Holding Cayman Research & Development Chart

BenQ BM Holding Cayman Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00 0.00

BenQ BM Holding Cayman Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
HKSE:02581
16GF Score
BenQ BM Holding Cayman Corp HKSE:02581
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BenQ BM Holding Cayman Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$0 Mil mean?
BenQ BM Holding Cayman (HKSE:02581) has a Research & Development of HK$0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on BenQ BM Holding Cayman and its competitors.
Is BenQ BM Holding Cayman's Research & Development too high?
BenQ BM Holding Cayman's current Research & Development is HK$0 Mil. Overall, BenQ BM Holding Cayman has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does BenQ BM Holding Cayman's Research & Development compare to HCA and THC?
BenQ BM Holding Cayman's Research & Development of HK$0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on BenQ BM Holding Cayman and its competitors. BenQ BM Holding Cayman's current Research & Development is HK$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BenQ BM Holding Cayman stock overvalued right now?
BenQ BM Holding Cayman (HKSE:02581) has a current Research & Development of HK$0 Mil. The current Research & Development is HK$0 Mil. BenQ BM Holding Cayman's overall GF Score™ is 16/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For BenQ BM Holding Cayman (HKSE:02581), the current Research & Development is HK$0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BenQ BM Holding Cayman Business Description

Address 71 Hexi Avenue, Jianye District, Jiangsu Province, Nanjing, CHN
BenQ BM Holding Cayman Corp is a healthcare services provider focusing on the provision of medical services in Mainland China. It provides diversified medical services to patients through the operation of general hospitals, covering disease diagnosis and treatment, health management and medical support services. It operates Nanjing BenQ Hospital and Suzhou BenQ Hospital in Mainland China. Its service offerings cover outpatient services, inpatient services, surgical services and related medical support services, and extend to ancillary medical services such as laboratory testing, imaging, nursing and other supporting services built around its core medical services. It operates in single segment and generates revenue from provision of hospital healthcare services in the PRC.
16GF Score

Get the complete analysis for HKSE:02581

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.58
Price